InfuSystem Holdings to be Acquired by Patient Square Capital
Ticker: INFU · Form: 8-K · Filed: May 20, 2024 · CIK: 1337013
| Field | Detail |
|---|---|
| Company | Infusystem Holdings, INC (INFU) |
| Form Type | 8-K |
| Filed Date | May 20, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $20 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: acquisition, going-private, merger
TL;DR
InfuSystem going private via Patient Square Capital deal, expected Q3 close.
AI Summary
InfuSystem Holdings, Inc. announced on May 16, 2024, that it entered into a definitive agreement to be acquired by an affiliate of Patient Square Capital. The transaction is expected to close in the third quarter of 2024, subject to customary closing conditions. This acquisition will result in InfuSystem becoming a privately held company.
Why It Matters
This acquisition will take InfuSystem Holdings private, potentially impacting its stock liquidity and future strategic direction under new ownership.
Risk Assessment
Risk Level: medium — The acquisition is subject to customary closing conditions, which introduces a degree of uncertainty until completion.
Key Players & Entities
- InfuSystem Holdings, Inc. (company) — Company being acquired
- Patient Square Capital (company) — Acquiring entity
- May 16, 2024 (date) — Date of agreement
- third quarter of 2024 (date) — Expected closing period
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing announces that InfuSystem Holdings, Inc. has entered into a definitive agreement to be acquired by an affiliate of Patient Square Capital.
Who is acquiring InfuSystem Holdings, Inc.?
An affiliate of Patient Square Capital is acquiring InfuSystem Holdings, Inc.
When is the acquisition expected to close?
The acquisition is expected to close in the third quarter of 2024.
What are the conditions for the acquisition to close?
The acquisition is subject to customary closing conditions.
What will happen to InfuSystem Holdings, Inc. after the acquisition?
InfuSystem Holdings, Inc. will become a privately held company.
Filing Stats: 543 words · 2 min read · ~2 pages · Grade level 11.5 · Accepted 2024-05-20 16:30:23
Key Financial Figures
- $20 million — orizing the Company to repurchase up to $20 million of the Company's outstanding common sto
Filing Documents
- infu-20240516.htm (8-K) — 27KB
- exhibit99105-20x2024sharer.htm (EX-99.1) — 12KB
- infusystem_safesmarttruste.jpg (GRAPHIC) — 760KB
- 0001628280-24-024370.txt ( ) — 1202KB
- infu-20240516.xsd (EX-101.SCH) — 2KB
- infu-20240516_lab.xml (EX-101.LAB) — 21KB
- infu-20240516_pre.xml (EX-101.PRE) — 12KB
- infu-20240516_htm.xml (XML) — 3KB
01 - Regulation FD Disclosure
Item 7.01 - Regulation FD Disclosure On May 20, 2024, InfuSystem Holdings, Inc. (the "Company") issued a press release announcing that the Company's Board of Directors has approved a stock repurchase program authorizing the Company to repurchase up to $20 million of the Company's outstanding common stock through June 30, 2026. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information furnished in this Item 7.01 — "Regulation FD Disclosure" of this Current Report on Form 8-K and the press release attached hereto as Exhibit 99.1 shall not be deemed "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of such section, and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.
01 - Financial Statements and Exhibits
Item 9.01 - Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 99.1 Press Release of InfuSystem Holdings, Inc. dated May 20, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INFUSYSTEM HOLDINGS, INC. By: /s/ Barry Steele Barry Steele Chief Financial Officer Dated: May 20, 2024